You are here: Industry Insights > AstraZeneca

News List

Astrazeneca COVID-19 vaccine effective against variants found in India firstwordpharma
June 23, 2021
AstraZeneca, citing a study, said its COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, as reported by U.S. News & World Report.
AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe worldpharmanews
June 21, 2021
AstraZeneca welcomed the ruling by the Court of First Instance in Brussels. The European Commission had requested 120 million vaccine doses cumulatively by the end of June 2021, and a total of 300 million doses by the end of September 2021.
Urgently trying to work with AstraZeneca, SII, Indian govt to resume shipments of COVID-19 vaccines: WHO expresspharma
June 21, 2021
The WHO is “urgently” trying to work with AstraZeneca, Serum Institute of India (SII) as well as the Indian government to restart shipments of COVID-19 vaccines to countries that had to suspend the rollout of second doses of vaccines amid the ...
Australia recommends AstraZeneca Covid-19 vaccine for people over 60 pharmaceutical-technology
June 18, 2021
The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended the use of the AstraZeneca Covid-19 vaccine in Australia for individuals aged above 60 years.
EU drug regulator records 415 cases of possible rare blood clotting firstwordpharma
June 18, 2021
The EU drug regulator said on Thursday it has received reports of 415 possible cases of thrombosis with thrombocytopenia syndrome in the EEA, out of over 50 million people who have gotten AstraZeneca and Johnson & Johnson's COVID-19 vaccines.
STORM CHASER Trial Fails to Meet Primary Endpoint in Post-Exposure Prevention of Symptomatic COVID-19 americanpharmaceuticalreview
June 17, 2021
AstraZeneca announced results from the STORM CHASER trial assessing the safety and efficacy of AZD7442, a long-acting antibody (LAAB) combination, for the prevention of symptomatic COVID-19 in participants recently exposed to the SARS-CoV-2 virus.
Italy's AIFA approves using different vaccine for second dose after AstraZeneca jab firstwordpharma
June 15, 2021
Italy's medicine agency AIFA said Italians under the age of 60 who received a first dose of the AstraZeneca COVID-19 vaccine Vaxzevria can be given a different vaccine when they get their second dose, as reported in Yahoo!News.
AstraZeneca COVID Vaccine Tied to Rare Cases of Low Blood Platelets drugs
June 10, 2021
The AstraZeneca COVID-19 vaccine may be linked with rare cases of low blood platelet levels, a new study suggests.
Imfinzi increases five year survival to 43 percent in Stage III lung cancer trial europeanpharmaceuticalreview
June 09, 2021
New data shows AstraZeneca’s Imfinzi (durvalumab) achieved an unprecedented five year survival rate of over 40 percent in patients with Stage III non-small cell lung cancer.
Calquence Demonstrates Fewer Incidences of Atrial Fibrillation vs Ibrutinib in Patients with Leukaemia americanpharmaceuticalreview
June 09, 2021
Final results from the head-to-head ELEVATE-RR Phase III trial of AstraZeneca’s Calquence (acalabrutinib) demonstrated non-inferior progression-free survival (PFS) and statistically significantly fewer events of atrial fibrillation versus ibrutinib in ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page